Mmastodon HealthHealth first seen 4 h ago, last 3 h ago, peak #4
Retatrutide trial hailed as new high-water mark for weight-loss drugs
Original: Blockbuster retatrutide trial signals a 'new high-water mark' for weight-loss drugs https://www.scientificamerican.com/a
A major clinical trial of retatrutide, Eli Lilly's experimental obesity drug, is being described as a 'new high-water mark' for weight-loss medications, according to Scientific American. The results suggest the drug may outperform existing GLP-1 treatments, fueling excitement among researchers and clinicians about the next generation of obesity therapies.
Why now: New trial results suggest retatrutide could surpass current weight-loss drugs, drawing wide attention in the health community.
retatrutideEli LillyScientific American
Rank over time, top of the chart is #1. 2 snapshots from 4 h ago to 3 h ago.
Evidence
- Blockbuster retatrutide trial signals a 'new high-water mark' for weight-loss drugs https://www.scientificamerican.com/article/blockbuster-retatrutide-trial-signals-a-new-high-water-mark-for-weight-loss-drugs/ # Science # Health # Medicine · scientific_american@robot.villas · 1
API: https://socialmediatrends-api.osmike.com/v1/trends/408142